Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.
2.

Sertindole : a review of its use in schizophrenia.

Murdoch D, Keating GM.

CNS Drugs. 2006;20(3):233-55. Review.

PMID:
16529528
3.

A review of the efficacy, tolerability and safety of sertindole in clinical trials.

Perquin L, Steinert T.

CNS Drugs. 2004;18 Suppl 2:19-30; discussion 41-3. Review.

PMID:
15461313
4.

Sertindole: a review of clinical efficacy.

Kane JM.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S59-63; discussion S63-4. Review.

PMID:
9690972
5.

Case histories illustrating the utility of sertindole in clinical practice.

Schuck P, van den Ameele H, Jaanson P, Ryckmans V, Hawley C.

CNS Drugs. 2004;18 Suppl 2:31-40; discussion 41-3. Review.

PMID:
15461314
6.

A review of the safety and tolerability of sertindole.

Hale AS.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S65-70. Review.

PMID:
9690973
7.

Sertindole: efficacy and safety in schizophrenia.

Lindström E, Levander S.

Expert Opin Pharmacother. 2006 Sep;7(13):1825-34. Review.

PMID:
16925508
8.

Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety.

Tamminga CA, Mack RJ, Granneman GR, Silber CJ, Kashkin KB.

Int Clin Psychopharmacol. 1997 Feb;12 Suppl 1:S29-35. Review.

PMID:
9179641
9.

Do we need another atypical antipsychotic?

Kasper S.

Eur Neuropsychopharmacol. 2008 Aug;18 Suppl 3:S146-52. doi: 10.1016/j.euroneuro.2008.04.006. Epub 2008 May 29. Review.

PMID:
18511242
10.

Drug safety and efficacy evaluation of sertindole for schizophrenia.

Karamatskos E, Lambert M, Mulert C, Naber D.

Expert Opin Drug Saf. 2012 Nov;11(6):1047-62. doi: 10.1517/14740338.2012.726984. Epub 2012 Sep 19. Review.

PMID:
22992213
11.

How much do novel antipsychotics benefit the patients?

Kasper S.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S71-7. Review.

PMID:
9690974
12.

Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.

Brown LA, Levin GM.

Pharmacotherapy. 1998 Jan-Feb;18(1):69-83. Review.

PMID:
9469684
13.

Efficacy and safety of sertindole in schizophrenia: a clinical review.

Zoccali RA, Bruno A, Muscatello MR.

J Clin Psychopharmacol. 2015 Jun;35(3):286-95. doi: 10.1097/JCP.0000000000000305. Review.

PMID:
25830594
14.

Sertindole in schizophrenia: efficacy and safety issues.

Muscatello MR, Bruno A, Micali Bellinghieri P, Pandolfo G, Zoccali RA.

Expert Opin Pharmacother. 2014 Sep;15(13):1943-53. doi: 10.1517/14656566.2014.947960. Epub 2014 Aug 1. Review.

PMID:
25084209
15.

Sertindole for the treatment of schizophrenia.

Azorin JM, Kaladjian A, Fakra E, Adida M.

Expert Opin Pharmacother. 2010 Dec;11(18):3053-64. doi: 10.1517/14656566.2010.536217. Review.

PMID:
21080854
16.

Emerging treatments in the management of schizophrenia - focus on sertindole.

Muscatello MR, Bruno A, Pandolfo G, Micò U, Settineri S, Zoccali R.

Drug Des Devel Ther. 2010 Sep 7;4:187-201. doi: 10.2147/DDDT.S6591. Review.

17.

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics.

Borison RL.

J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):24S-29S. Review.

PMID:
7537285

Supplemental Content

Support Center